Abbott Labs and Reckitt Benckiser Shares Fall

Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
That baby formula trial Abbott and Reckitt had won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Reckitt still assessing options for Mead Johnson infant-formula “exit”
Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula business.
Reuters9d
Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help
LONDON, March 6 (Reuters) - Britain's Reckitt Benckiser (RKT.L), opens new tab, the maker of Strepsils throat lozenges and ...
Lysol Maker Reckitt Benckiser Beats Profit Expectations Despite Lower Sales
Adjusted profit of nearly £3.5 billion came in ahead of expectations for 2024 as the consumer-goods company continues to ...
Reckitt hikes dividend for investors amid efficiency drive
On Wednesday, Reckitt said its operating profit fell 4.2 per cent to £2.43billion last year, while revenue fell 3 per cent to ...
Investing.com India1d
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Reckitt Benckiser Group Plc. (RBGLY) Stock Forecasts
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Reckitt Pro Solutions announced as hygiene sponsor for The Cleaning Show 2025
Registration for The Cleaning Show 2025 is open. Entry remains free, but visitors are encouraged to pre-register online to secure their place at the ...
Reckitt Benckiser downgraded to Neutral from Buy at BofA
BofA downgraded Reckitt Benckiser (RBGLY) to Neutral from Buy citing a lack of near-term catalysts and its preference for Unilever. Optimize ...